Third component of complement in cystic fibrosis

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
• The complement system, including complement component 3 (C3), plays a role in immune responses.
• Previous research has not fully elucidated the role of C3 in CF pathogenesis.

Purpose of the Study:

• To investigate C3 levels and phenotypes in individuals with cystic fibrosis.
• To determine the correlation between C3 concentration and clinical severity in CF patients.
• To analyze C3 phenotypes and gene frequencies in CF patients, their families, and healthy controls.

Main Methods:

• Quantitative analysis of C3 levels in serum samples.
• Phenotyping of C3 using established genetic markers.
• Correlation analysis between C3 levels and the Shwachman-Kulczycki (S-K) score for clinical assessment.
• Comparison of C3 levels, phenotypes, and gene frequencies across different study groups.

Main Results:

• Significant elevations in mean C3 levels were found in CF patients, CF parents, and a specific subgroup of siblings (SS females).
• C3 concentration in CF patients showed a positive correlation with the degree of clinical impairment (S-K score).
• No significant differences were observed in C3 phenotype prevalence or S and F gene frequencies among the studied groups.

Conclusions:

• Elevated C3 levels are associated with cystic fibrosis and may be inherited from parents.
• C3 levels correlate with clinical severity in CF patients, suggesting a potential role in disease progression.
• C3 genetic variations do not appear to be a primary factor in the observed C3 level differences in CF.